Bruker (BRKR) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.59% |
| Dec 31, 2025 | -14.02% |
| Sep 30, 2025 | 13.16% |
| Jun 30, 2025 | -43.25% |
| Mar 31, 2025 | 23.65% |
| Dec 31, 2024 | -9.10% |
| Sep 30, 2024 | -39.93% |
| Jun 30, 2024 | -75.36% |
| Mar 31, 2024 | -62.68% |
| Dec 31, 2023 | 25.12% |
| Sep 30, 2023 | -39.73% |
| Jun 30, 2023 | 10.82% |
| Mar 31, 2023 | -24.58% |
| Dec 31, 2022 | -39.88% |
| Sep 30, 2022 | -26.33% |
| Jun 30, 2022 | 25.60% |
| Mar 31, 2022 | -7.38% |
| Dec 31, 2021 | -3.82% |
| Sep 30, 2021 | -35.38% |
| Jun 30, 2021 | -65.32% |
| Mar 31, 2021 | -26.53% |
| Dec 31, 2020 | 7.96% |
| Sep 30, 2020 | -5.26% |
| Jun 30, 2020 | 0.90% |
| Mar 31, 2020 | -77.56% |
| Dec 31, 2019 | 9.95% |
| Sep 30, 2019 | 24.94% |
| Jun 30, 2019 | -1.30% |
| Mar 31, 2019 | -27.58% |
| Dec 31, 2018 | -79.45% |
| Sep 30, 2018 | -8.34% |
| Jun 30, 2018 | -20.96% |
| Mar 31, 2018 | 57.07% |
| Dec 31, 2017 | 29.33% |
| Sep 30, 2017 | 38.47% |
| Jun 30, 2017 | -23.15% |
| Mar 31, 2017 | -17.01% |
| Dec 31, 2016 | -6.80% |
| Sep 30, 2016 | 35.92% |
| Jun 30, 2016 | 18.21% |
| Mar 31, 2016 | 6.03% |
| Dec 31, 2015 | 28.94% |
| Sep 30, 2015 | -30.65% |
| Jun 30, 2015 | 18.18% |
| Mar 31, 2015 | -1.09% |